G. González

ORCID: 0009-0002-2587-0857
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Organ Transplantation Techniques and Outcomes
  • Liver Disease and Transplantation
  • Renal Transplantation Outcomes and Treatments
  • Organ Donation and Transplantation
  • Pediatric Hepatobiliary Diseases and Treatments
  • Congenital Anomalies and Fetal Surgery
  • Clinical Nutrition and Gastroenterology
  • Pregnancy and Medication Impact
  • Neonatal and Maternal Infections
  • Liver Disease Diagnosis and Treatment
  • Transplantation: Methods and Outcomes
  • Stress Responses and Cortisol
  • Neuroscience and Neuropharmacology Research
  • Neonatal Health and Biochemistry
  • Genetic and Kidney Cyst Diseases
  • Neonatal Respiratory Health Research
  • Chronic Myeloid Leukemia Treatments
  • Preterm Birth and Chorioamnionitis
  • Chronic Lymphocytic Leukemia Research
  • Gastric Cancer Management and Outcomes
  • Sepsis Diagnosis and Treatment
  • Metabolism and Genetic Disorders
  • Central Venous Catheters and Hemodialysis
  • Renal and Vascular Pathologies
  • Childhood Cancer Survivors' Quality of Life

Hospital Luis Calvo Mackenna
2008-2023

University of Chile
2001-2023

Clínica Las Condes
2004-2022

Hospital Universitario de Canarias
2013-2018

In-Q-Tel
2015

Center for Devices and Radiological Health
2013

St. Jude Children's Research Hospital
2011

Universidad de León
2010

Hospital Universitario Virgen del Rocío
2006-2008

Hospital del Salvador
2005

This study aimed to investigate the current therapeutic management of patients with early-stage HER2-positive (HER2+) breast cancer in Spain, while also exploring perceptions surrounding HER2DX terms its credibility, clinical relevance, and impact on decision-making. Understanding these aspects is crucial for optimizing treatment strategies enhancing patient outcomes context HER2+ cancer.

10.1007/s12094-024-03409-4 article EN cc-by Clinical & Translational Oncology 2024-04-23

Aim : To investigate whether the serum levels of interleukin‐1β, 6, 8, tumour necrosis factor‐α and soluble receptor IL‐2 are useful in diagnosis neonatal sepsis, their diagnostic power is increased when combination with classical markers such as C‐reactive protein white blood cell count. Methods Blood samples were collected at admission from 40 neonates suspected infection. Patients included different groups according to bacteriological laboratory results: Group I consisted 20 newborns...

10.1111/j.1651-2227.2003.tb00530.x article EN Acta Paediatrica 2003-02-01

To investigate whether cord blood levels of C-reactive protein, interleukin-1beta, interleukin-6, interleukin-8, tumour necrosis factor-alpha and the soluble receptor interleukin-2, are useful markers in diagnosis early neonatal sepsis.Umbilical samples were obtained at birth from 261 neonates, but 5 these newborns excluded study. Group I included 10 that developed sepsis with a positive culture; II 11 non-infectious perinatal diseases; III, which served as control group, randomly selected...

10.1080/080352501317061602 article EN Acta Paediatrica 2001-10-01

Aim : To investigate whether cord blood levels of C‐reactive protein, interleukin‐1β, interleukin‐6, interleukin‐8, tumour necrosis factor‐α and the soluble receptor interleukin‐2, are useful markers in diagnosis early neonatal sepsis. Design Umbilical samples were obtained at birth from 261 neonates, but 5 these newborns excluded study. Group I included 10 that developed sepsis with a positive culture; II 11 non‐infectious perinatal diseases; III, which served as control group, randomly...

10.1111/j.1651-2227.2001.tb03250.x article EN Acta Paediatrica 2001-10-01

Abstract Background Central venous catheters (CVC) facilitate the management of patients with cancer. Optimal timing for placement a CVC is controversial. We sought to determine whether early in children acute lymphoblastic leukemia (ALL), group at high risk infection and thrombosis, was associated an increased rate surgical complications. Procedure evaluated incidence factors complications ALL diagnosed between 2004 2009 single pediatric cancer center. Results One hundred seventy‐two were...

10.1002/pbc.24010 article EN Pediatric Blood & Cancer 2011-12-11

The aim of the current study was to compare results in pediatric renal transplantation patients with and without SBP. Between 2001 2013, a total 168 kidney transplants were performed at our center. A retrospective analysis recipients divided into two groups: NB Incidence surgical complications after procedure, graft patient survival evaluated. 155 (92%) complete data analyzed, 13 that had previous bladder surgeries excluded (11 VUR surgery transplants), recipients: 123 (79%) NB, 32 (21%)...

10.1111/petr.12567 article EN Pediatric Transplantation 2015-08-10

Between 1989 and 2003, 100 transplants were performed in 96 patients at the pediatric nephrology unit of Calvo Mackenna Children's Hospital. Mean age 10.9 +/- 3.9 yr (1-17.6), 30% from LD. Donors younger than 5 five all recipients received an 'en bloc' graft. Original disease was hypo/dysplasia 27%, reflux nephropathy 22 17% chronic glomerulonephritis. The immunosuppressive protocol during first period (n = 56, 1989-2000): Cyclosporine, steroids azathioprine, second 44, 2001-2003): FK,...

10.1111/j.1399-3046.2005.00423.x article EN Pediatric Transplantation 2005-10-21

Summary: We studied human immunodeficiency virus (HIV)-seroprevalence among children with clinically diagnosed tuberculosis (TB) and compared the clinical features response to short-term anti-TB therapy of without HIV infection in Santo Domingo, Dominican Republic. Children aged 18-59 months new-onset, TB were tested for antibodies, their recorded, a standard 6-month regimen daily isoniazid rifampicin streptomycin pyrazinamide first 2 was assessed. To increase number HIV-infected available...

10.1097/00042560-199610010-00006 article EN Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1996-10-01

In multiple system atrophy (MSA) and progressive supranuclear palsy (PSP), the absence of surrogate endpoints makes clinical trials long expensive. We aim to determine annualized whole-brain rates (a-WBAR) in idiopathic Parkinson’s disease (IPD), MSA, PSP. Ten healthy controls, 20 IPD, 12 PSP, 8 MSA patients were studied using a volumetric MRI technique (SIENA). a-WBAR was<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mn...

10.1155/2016/9631041 article EN cc-by Parkinson s Disease 2016-01-01
Coming Soon ...